Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1459

1.

GASTRO-HEP News.

Alleman S.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):494. No abstract available.

2.

Hemorrhoidal Banding and Anesthesia Partnerships as Ancillary Services to Gastroenterology Practices.

Kreger J, Guttenplan M.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):488-490. No abstract available.

3.

Radiofrequency Ablation for the Treatment of Barrett Esophagus With Low-Grade Dysplasia.

Wolfsen HC.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):488-490. No abstract available.

4.

The Use of Statins in Patients With Cirrhosis.

Kaplan DE.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):485-487. No abstract available.

5.

Highlights From the New ACG Guideline on Crohn's Disease Management.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):482-484. No abstract available.

6.

Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.

Gold SL, Cohen-Mekelburg S, Schneider Y, Steinlauf A.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):470-481.

7.

The Role of Allergy Testing in Eosinophilic Esophagitis.

Anyane-Yeboa A, Wang W, Kavitt RT.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):463-469.

8.

Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus.

Saab S, Ahn T, McDaniel T, Yanny B, Tong MJ.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):459-462.

9.

New ACG Guideline for the Management of Crohn's Disease.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Aug;14(8):451. No abstract available.

10.

Understanding and Managing IBS and CIC in the Primary Care Setting.

Cash BD.

Gastroenterol Hepatol (N Y). 2018 May;14(5 Suppl 3):3-15. No abstract available.

11.

Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection.

Kim WR.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):439-442. No abstract available.

12.

The Emerging Role of Brain-Gut Therapies for Irritable Bowel Syndrome.

Riehl ME.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):436-438. No abstract available.

13.

Endoscopic Management of Barrett Esophagus.

Shaheen NJ.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):433-435. No abstract available.

14.

Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.

Tabibian JH, Ali AH, Lindor KD.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):427-432.

15.

GASTRO-HEP News.

Alleman S.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):426. No abstract available.

16.

The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Lin SC, Cheifetz AS.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):415-425.

17.

Overview of Updated Practice Guidelines for Pediatric Nonalcoholic Fatty Liver Disease.

Shah J, Okubote T, Alkhouri N.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):407-414.

18.

Brain-Gut Therapies and Irritable Bowel Syndrome.

Lichtenstein GR.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):399. No abstract available.

19.

The Use of Peroral Endoscopic Myotomy for the Management of Achalasia.

Khashab MA.

Gastroenterol Hepatol (N Y). 2018 Jun;14(6):387-389. No abstract available.

20.

Update on HCC Management and Review of the New EASL Guidelines.

Aghemo A.

Gastroenterol Hepatol (N Y). 2018 Jun;14(6):384-386. No abstract available.

Supplemental Content

Loading ...
Support Center